Career history of Harish Shantharam
Former positions of Harish Shantharam
| Companies | Position | Start | End |
|---|---|---|---|
| CYMABAY THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 2024-01-23 | 2024-03-21 |
| Director of Finance/CFO | 2023-05-21 | 2024-03-21 | |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 2011-09-30 | 2022-04-30 |
| AMGEN INC. | Corporate Officer/Principal | 2003-12-31 | 2011-10-31 |
Training of Harish Shantharam
| UCLA Anderson School of Management | Masters Business Admin |
| The University of Texas at Arlington | Graduate Degree |
Statistics
International
| United States | 6 |
Operational
| Corporate Officer/Principal | 2 |
| Comptroller/Controller/Auditor | 1 |
| Director of Finance/CFO | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| AMGEN INC. | Health Technology |
| Private companies | 1 |
|---|---|
CymaBay Therapeutics, Inc.
 CymaBay Therapeutics, Inc. BiotechnologyHealth Technology CymaBay Therapeutics, Inc. engages in the provision and development of access to therapies for patients with liver and other chronic diseases with high unmet medical needs. Its products pipeline includes Seladelpar, MBX-2982, CB-0406, and CB-001. The company was founded on October 5, 1988 and is headquartered in Newark, CA. | Health Technology |
- Stock Market
- Insiders
- Harish Shantharam
- Experience
